11 Apr 2024 --- New research has revealed the cardiometabolic benefits of AB-Biotics’ AB-Life Lactiplantibacillus plantarum probiotic strains in combating atherosclerotic cardiovascular diseases (ACVDs), the number one cause of death, globally. This study shows the underlying mechanisms of how AB-Life — which contains the L. plantarum strains, KABP 011, KABP 012 and KABP 013 — modulates digestive processes to bolster heart health.
